India’s Patent Office Rules Against Boehringer Ingelheim Viramune Patent

MUMBAI - India's Patent Office in New Delhi on June 19 discarded a patent application for a pediatric version of German drug maker Boehringer Ingelheim's antiretroviral drug Viramune (nevirapine)